Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Feres

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
Journal of the American College of Cardiology|November 12, 2021
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic RiskTullio Palmerini, Antonio Giulio Bruno, Björn Redfors, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 6, 2026
Real-World Performance and Mid-Term Durability of the Myval Transcatheter Heart Valve in Patients Undergoing Transcatheter Aortic Valve ReplacementAlberto Colella Cervone, Dimytri Alexandre de Alvim Siqueira, Tacianne Rolemberg Braga Delamain, et al.
JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.
International Journal of Cardiology. Heart & Vasculature|August 4, 2021
High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort studyPatrícia O Guimarães, Francis R de Souza, Renato D Lopes, et al.
Journal of the American College of Cardiology|April 22, 2017
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary StentingTullio Palmerini, Letizia Bacchi Reggiani, Diego Della Riva, et al.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2025
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK TrialOsama Soliman, Elfatih A Hasabo, Niels van Royen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2024
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosisNiels van Royen, Ignacio J Amat-Santos, Martin Hudec, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
Journal of the American College of Cardiology|November 12, 2021
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic RiskTullio Palmerini, Antonio Giulio Bruno, Björn Redfors, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 6, 2026
Real-World Performance and Mid-Term Durability of the Myval Transcatheter Heart Valve in Patients Undergoing Transcatheter Aortic Valve ReplacementAlberto Colella Cervone, Dimytri Alexandre de Alvim Siqueira, Tacianne Rolemberg Braga Delamain, et al.
JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.
International Journal of Cardiology. Heart & Vasculature|August 4, 2021
High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort studyPatrícia O Guimarães, Francis R de Souza, Renato D Lopes, et al.
Journal of the American College of Cardiology|April 22, 2017
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary StentingTullio Palmerini, Letizia Bacchi Reggiani, Diego Della Riva, et al.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2025
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK TrialOsama Soliman, Elfatih A Hasabo, Niels van Royen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2024
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosisNiels van Royen, Ignacio J Amat-Santos, Martin Hudec, et al.
Pageof 13